DiscoverCritical Care Perspectives in Emergency MedicineCefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Update: 2024-06-07
Share

Description

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Critical Care Perspectives in Emergency Medicine